NRIXNasdaqPharmaceutical PreparationsFiscal year ends November 30
Nurix Therapeutics, Inc.
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 13, 2026
$24.93+0.51 (+2.09%)
Close on Oct 19, 2026
- Market cap
- $2.90B
- P/E (TTM)
- 10.8
- Dividend yield
- 0.00%
SEC filings
40 of Nurix Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Aug 31, 2026 | Oct 13, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 12, 2026 | Oct 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | May 31, 2026 | Jul 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2026 | Jul 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 6, 2026 | Jun 8, 2026 | SEC EDGAR |
| Current report | 8-K | May 15, 2026 | May 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Feb 28, 2026 | Apr 8, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 8, 2026 | Apr 8, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 15, 2026 | Mar 27, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 6, 2026 | Mar 6, 2026 | SEC EDGAR |
| Annual report | 10-K | Nov 30, 2025 | Jan 28, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 28, 2026 | Jan 28, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 6, 2025 | Dec 9, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 22, 2025 | Oct 22, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 22, 2025 | Oct 22, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Aug 31, 2025 | Oct 9, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 9, 2025 | Oct 9, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 3, 2025 | Sep 3, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 19, 2025 | Aug 22, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | May 31, 2025 | Jul 9, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2025 | Jul 9, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 19, 2025 | May 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Feb 28, 2025 | Apr 8, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 8, 2025 | Apr 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 19, 2025 | Mar 28, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2025 | Mar 13, 2025 | SEC EDGAR |
| Annual report | 10-K | Nov 30, 2024 | Jan 28, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 28, 2025 | Jan 28, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2024 | Dec 10, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2024 | Oct 31, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 15, 2024 | Oct 16, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Aug 31, 2024 | Oct 11, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 11, 2024 | Oct 11, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 5, 2024 | Sep 5, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | May 31, 2024 | Jul 11, 2024 | SEC EDGAR |